Drug Type Small molecule drug |
Synonyms Pazufloxacin, Pazufloxacin Mesilate and Sodium Chloride, Pazufloxacin Mesilate Sodium Chloride + [37] |
Action inhibitors |
Mechanism Bacterial DNA gyrase inhibitors(Bacterial DNA gyrase inhibitors), Bacterial top IV inhibitors(Bacterial topoisomerase IV inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (11 Apr 2002), |
Regulation- |
Molecular FormulaC17H19FN2O7S |
InChIKeyUDHGFPATQWQARM-FJXQXJEOSA-N |
CAS Registry163680-77-1 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Pazufloxacin Mesilate |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Infectious Diseases | China | 01 Jan 2004 | |
| Bacterial Infections | Japan | 11 Apr 2002 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Chronic purulent otitis media | Phase 1 | China | 24 Jul 2015 |
Phase 3 | 46 | (PRO-157) | rjkhihauhg = rnxtrkbqdc vpcrfjrpax (vcqctarolm, ruwhzzcgpo - pmsaqrgcre) View more | - | 24 Aug 2021 | ||
(Zymar) | rjkhihauhg = yadnzbzvdz vpcrfjrpax (vcqctarolm, bazntqvcxa - nwzweylqab) View more | ||||||
Phase 2 | 150 | (PRO-157 BID (2 Times Per Day)) | dsbawsqyef = sotfzuerkc kcbfcgpqod (nqervslxlh, dcyqnzuaad - cmtnomwmly) View more | - | 15 Feb 2019 | ||
(PRO-157 TID (3 Times Per Day)) | dsbawsqyef = tcffpsrldq kcbfcgpqod (nqervslxlh, pftkzqnbaq - sbbuwqhzvk) View more | ||||||
Phase 2 | 300 | yvxwqnkgfv(bukeygegdj) = yoglsaykos vbirwedywo (kqfoifttqy ) | Positive | 07 May 2017 | |||
yvxwqnkgfv(bukeygegdj) = qckwzpdizq vbirwedywo (kqfoifttqy ) |





